Our History

Metal implants, screws and K-wires have been the dominating and ultimate implants of choice for clinical treatment of fractures including head, neck, fingers and other complex traumas. Yet, some alternative treatments have been tried by the use of existing

biomedical glues.


Already in 1986 a biomedically approved adhesive - Histoacryl - was introduced at the Department of Neurosurgery Karolinska University Hospital in Stockholm, Sweden, for bone fracture fixation. Unfortunately, the adhesive was not successful mainly due to its suboptimal characteristics regarding mechanical insufficiency,cell toxicity, uncontrolled tissue adhesion. Based on the evermore need for alternative adhesive technology that can challenge rigid implants, an interdisciplinary collaboration was set between Neurosurgery, Karolinska University Hospital and the Division of Coating Technology KTH in 2006.


The initial groundbreaking research resulted in the introduction of the FRAP (Fiber Reinforced Adhesive Patch) technology as an innovative alternative treatment to metal implants for fracture treatment.  The continuous research has resulted in patent applications in which Biomedical Bonding AB holds all rights for future commercial exploitation.


© 2021 by Biomedical Bonding AB

  • BMB Linkedin
  • Facebook Social Icon